FP722May07_slides_AR_AS_Athens.ppt

7th Framework Program

2007-2013

Achilleas D. Stalios

[email protected] Commission -DG Research-Industrial Technologies Directorate -Materials-

Funding programmes

Education

- Lifelong Learning Programme

Research- FRAMEWORK PROGRAMMES

- Seventh Framework Programme for research and

development

Innovation

- Competitiveness and Innovation Programme

Structural and Cohesion Funds

R&D – European weaknesses

EU-25 US Japan

R&D intensity (% of GDP) (3) 1.97 2.59 3.12

Share of R&D financed by industry (%) (2) 55.9 63.1 73.9

Researchers per thousand labour force (FTE) (3) 5.5 9.0 9.7

Share of world scientific publications (%) (3) 38.3 31.1 9.6

Scientific publications per million population (3) 639 809 569

Share of world triadic patents (%) (1) 31.5 34.3 26.9

Triadic patents per million population (1) 30.5 53.1 92.6

High-tech exports as a share of total manufacturing exports (%) (3) 19.7 28.5 26.5

Share of world high-tech exports (%) (2) 16.7 20.0 10.6

Note: (1) 2000 data (2) 2002 data (3) 2003 data

Towards The 7th Framework Programme

2007-2013 (‘co-decision’)

New FP7

FP7 : What’s new?

Mainelements:

Duration increased to seven years

Total budget of €50.5 billion=>63% increase

Frontier research (~ €1.1 billion per year) New structure: Cooperation – Ideas – People – Capacities Flexible funding schemes

Joint Technology initiatives

Simpler procedures Outsourcing

http://ec.europa.eu/research/fp7/events/07_feb_07_prog_en.html

FP7 2007 –2013 Specific Programmes

+

Ideas – Frontier Research

Capacities – Research Capacity

People – Marie Curie Actions

Cooperation – Collaborative research

JRC (non-nuclear)

JRC (nuclear)

Euratom

FP7/ Budget

Cooperation32 413 €M

Ideas7 460 €M

People4 728 €M

Capacities4 217 €MNon-nuclear JRC

1 751 €M

Total European Community budget for non-nuclear research: 50.52 € billions

FP7/ Cooperation programme http://cordis.europa.eu/fp7/cooperation

Funding Schemes

• Collaborative projects– Projects can range from small or medium-scale focused

research actions (CP)– Large‑scale integrating projects for achieving a defined

objective. (Large CP)

• Coordination and support actions– Support for activities aimed at coordinating or

supporting research activities and policies (networking, exchanges, trans-national access to research infrastructures, studies, conferences, etc.). (CA) and (SSA)

• Networks of Excellence

FP7/ Cooperation programme

FP7 /Cooperation programme (collaborative research)

10 Themes1. Health

2. Food, agriculture & fisheries and biotechnology

3. Information Society and Communication Technologies -> ICT

4. Nanosciences, nanotechnologies, Materials & new Production technologies -> NMP

5. Energy

6. Environment (including climate change)

7. Transport (including aeronautics)

8. Socio-economic sciences & the humanities

9. Security

10. Space

M€

1 430/80.3 31 May

1 400/34.5 19 Jun

623/58.5 10 May

4 160/229 3 May

1 890/200 2 May

2 350/237 3 May

3 475/364 4May1st

9 050/1019 8 May

1 935/192 2 May

6 100/628 19 April

4. Nanosciences, Nanotechnologies, Materials

and new Production Technologies

• Nanosciences and nanotechnologies

• Materials

• New production

• Integration of technologies for

industrial applications

Workprogrammes include indicative priorities for future calls!!!

NMP-2007-2.1.1Large CP

Nanostructured polymer-matrix composites

NMP-2007-2.1.2CP

Nanostructured coatings and thin films

NMP-2007-2.2-1Large CP

Organic materials for electronics and photonics

NMP-2007-2.2-2CP

Nanostructured materials with tailored magnetic properties

NMP-2007-2.2-3CP

Advanced material architectures for energy conversion

NMP-2007-2.3-1 Large CP

Highly porous bioactive scaffolds controlling angiogenesis for tissue engineering

NMP-2007-2.4-2CP

Nanostructured catalysts with tailor-made functional surfaces

NMP-2007-2.4-3CP

Renewable materials for functional packaging applications

NMP-2007-2.5-2CP

Modelling of microstructural evolution under work conditions and in materials processing

Selected topics in Materials and Selected topics in Materials and Nanotechnology in FP7Nanotechnology in FP7NanomaterialsNanomaterials

ENERGY-2007.1.2.4CP

Novel nanostructured materials for hydrogen storage

ENERGY-2007.1.1.1CP

Basic research for materials and processes for Polymer Electrolyte Membrane Fuel Cells (PEMFC)

ENERGY-2007.1.1.2CP

Basic research on materials and processes for High Temperature Fuel Cells (SOFC & MCFC)

ENERGY-2007.1.2.1CP

New materials and processes for advanced electrolysers

ENERGY-2007.1.2.2CP

New materials and processes for advanced multi-fuel processors

AAT-2007.1.1.2CP, CSA

Aerostructures

Nanomaterials –cont’dNanomaterials –cont’d

ICT-2007.3.1CP, NoE, CSA

Next generation nanoelectronics components and electronics integration

ICT-2007.8.1CP, CSA (CA only)

Nano-scale ICT devices and systems

NanoelectronicsNanoelectronics

NanoscienceNanoscienceNMP-2007-1.1-1CP

Nano-scale mechanisms of bio/non-bio interactions

NMP-2007-1.1-2CP

Self-assembling and self-organisation

NMP-2007-1.1-3CSA

Support to ICPC researchers in nanotechnology and creation of a free and open electronic archive of nanosciences and nanotechnologies scientific and technical publications

NMP-2007-1.1-4CSA

Development of methodology, collection and elaboration of scientific-technical and socio-economic data and studies on nanosciences and nanotechnologies, including risk assessment, and establishment of an observatory

NMP-2007-1.1-5CSA (ERANET)

ERANET Plus in nanosciences


Pilot lines to study, develop and up-scale nanotechnology-based processes from laboratory

NMP-2007-1.2-2SME-targeted CP

Equipment and methods for nanotechnology

NMP-2007-1.2-3CSA

Analysis of the ethical, regulatory, social and economic environment of nanomedicine

NMP-2007-1.2-4CSA

Coordination in nanometrology

NMP-2007-1.2-5CSA

Examining capacity building in nanobiotechnology


Rapid Manufacturing Concepts for Small Series Industrial Production


Processes and Equipment for High Quality Industrial Production of 3-Dimensional Nanosurfaces


Production Technologies and equipment for Micro-Manufacturing


Multifunctional materials for future vehicles

Technology developmentTechnology development


Specific, easy-to-use portable devices for measurement and analysis

NMP-2007-1.3-2CP

Risk assessment of engineered nanoparticles on health and the environment

NMP-2007-1.3-3CSA

Scientific review on the data and studies on the potential impact on health, safety and the environment of engineered nanoparticles

NMP-2007-1.3-4CSA

Creation of a critical and commented database on the health, safety and environmental impact of nanoparticles

NMP-2007-1.3-5CSA

Coordination in studying the environmental, safety and health impact of engineered nanoparticles and nanotechnology based materials and products

HEALTH-2007-1.3-4CP

Alternative testing strategies for the assessment of the toxicological profile of nanoparticles used in medical diagnostics

SiS-2007-1.2.3.2-CTCSA

Science in Society: Nanoscience and Nanotechnology

Impact assessment and societal issuesImpact assessment and societal issues


Substantial innovation in the European medical industry: development of nanotechnology-based systems for in-vivo diagnosis and therapy (in coordination with topics HEALTH-2007-2.4.1-7 and HEALTH-2007-1.2-3)

HEALTH-2007-2.4.1-7CP

Improving targeted drug delivery to cancer cells for cancer therapeutics other than gene therapy

HEALTH-2007-1.2.3Large CP

Novel targeted imaging probes for early in vivo diagnosis and/or evaluation of response to therapy

HEALTH-2007-1.4.4Large CP 2nd call

Development of emerging gene therapy tools and technologies for clinical application

ICT-2007-5.1Large CP, CSA

Personal Health Systems for Monitoring and Point-of-Care diagnostics

NanomedicineNanomedicine

ICT-2007.3.6CP, NoE, CSA 2nd call*

Micro/nanosystems

ICT-2007.3.5CP, NoE, CSA 2nd call

Photonic components and subsystems

ICT-2007-CCP, CSA (CA only)

FET (Future and Emerging Technologies) Open(Open call for bottom-up activities)

AAT-2007.6.1.4CP, CSA

Life-cycle [of air vehicles, including increased use of nanotechnologies]

KBBE-2007-2-3-04CP

Nano-devices for quality assurance, food safety and product properties

KBBE-2007-2-4-04CP

Innovative and safe packaging

KBBE-2007-2-5-02CP

Converging technologies and their potential for the food area

Other Important TopicsOther Important Topics

* 2nd for ICT call will be public May/June 2007

1. S/T quality(in relation to the topics addressed by the call)

2. Implementation 3. Impact

• Sound concept, and quality of objectives

• Progress beyond the state-of-the-art

• Quality and effectiveness of the S/T methodology and work plan

• Appropriateness of the management structure and procedures

• Quality and relevant experience of the individual participants• Appropriate allocation and justification of committed resources

• Contribution to impacts listed in the work programme under relevant topic/activity• Appropriateness of dissemination and/or exploitation of projects results, plans

FP7 /Collaborative projects Evaluation Criteria

Potential Joint Technology Initiative: – New Nanoelectronics Approaches– Hydrogen and Fuel Cells for Sustainable Energy Future– Aeroanutics and Air Transport– Global Monitoring for Environment and Securitu– Embedded Systems– Innovative Medicines Initiative

Technology Platforms related to Theme 4:– ENIAC: European Nanoelectronics Initiative Advisory Council– NanoMedicine- Nanotechnologies for Medical Applications– Technology Platform on Sustainable Chemistry– Steel– Future Textiles & Clothing– Manufacturing Technologies– The European Construction Technology Platform– Industrial Safety– The European Hydrogen and Fuel Cell Technology Platform– The European Technology Platform on Photovoltaics– Photonics 21: The Photonics Technology Platform– EUMAT: European TP for Advanced Engineering Materials and Technologies– European Aluminum Technology Platform

FP7/ Ideas

• Frontier research• Investigator-driven• Support to individual teams

through Europe-wide competition • Governance: European Research

Council • Executive Agency

http://cordis.europa.eu/fp7/ideas

FP7/ Ideas Scientific Council

• 22 high level scientists reflecting the full scope of European research, nominated by Commission

Dr. Claudio BORDIGNON (IT) Professor Manuel CASTELLS (ES) Prof. Dr. Paul J. CRUTZEN (NL) Prof. Mathias DEWATRIPONT (BE) Dr. Daniel ESTEVE (FR) Prof. Pavel EXNER (CZ) Prof. Dr. Hans-Joachim FREUND (DE) Prof. Wendy HALL (UK) Prof. Dr. Carl-Henrik HELDIN (SE) Prof. Dr. Fotis C. KAFATOS (GR) Prof. Dr. Michal KLEIBER (PL) Prof. Norbert KROO (HU) Prof. Maria Teresa V.T. LAGO (PT) Dr. Oscar MARIN PARRA (ES) Prof Robert MAY (UK) Prof. Helga NOWOTNY (AT)Prof. Christiane NÜSSLEIN-VOLHARD (DE) Dr. Leena PELTONEN-PALOTIE (FI) Prof. Alain PEYRAUBE (FR) Dr. Jens R. ROSTRUP-NIELSEN (DK)Prof. Salvatore SETTIS (IT) Prof. Dr. Rolf M. ZINKERNAGEL (CH)

http://europa.eu.int/erc/

FP7 / Ideas

Role of the Scientific Council• Establish overall scientific strategy and preparation of work programmes (incl. calls for proposals, evaluation criteria)

• Define scientific management: peer review methodology; selection and accreditation of experts; monitor quality of operations and evaluate programme implementation

• Assure communication with the scientific community

Two streams of activity are foreseen:

- Early stage independent investigators (“Starting Grants”)

> 2 < 9 years after PhDup to 5 years project~1/3 of the annual budget:

300-350 M€ per year (200 grants)

- Established Investigators (“Advanced Grants”)

FP7 / IdeasWork Programme / Launch strategy

FP7 / IDEASStarting Grants / Evaluation criteria

1. Principal Investigator: Potential to perform world class researchQuality of research output: Has the Principal Investigator published in high quality peer reviewed

journals or the equivalent? To what extent are these publications ground-breaking and demonstrative of independent creative thinking and capacity to go significantly beyond the state of the art?

Intellectual capacity and creativity: To what extent does the Principal Investigator's record of research collaborations, project conception, supervision of students and publications demonstrate that he/she isable to confront major research challenges in the field, and to initiate new productive lines of thinking?

2. Quality of the proposed research projectGround-breaking nature of the research: Does the proposed research address important challenges in

the field(s) addressed? Does it have suitably ambitious objectives, which go substantially beyond thecurrent state of the art (e.g. including trans-disciplinary developments and novel or unconventiona approaches)?

Potential impact: Does the research open new and important scientific, technological or scholarly horizons?

Methodology: a) is the outlined scientific approach (including the activities to be undertaken by the individual team members) feasible? (Stage 1) b) is the proposed research methodology (including when pertinent the use of instrumentation, other type of infrastructures etc.) comprehensive and appropriate for to the project? Will it enable the goals of the project convincingly to be achieved within the timescales and resources proposed and the level of risk associated with a challenging research project? (Stage 2)

3. Research EnvironmentTransition to independence: Will the proposed project enable the Principal Investigator to make or

consolidate the transition to independence?Hosting institution (normally applicant legal entity): Does the institution hosting the project have

most of the infrastructure necessary for the research to be carried out? Is it in a position to provide an appropriate intellectual environment and infrastructural support and to assist in achieving the ambitions for the project and the Principal Investigator?

Participation of other legal entities: If it is proposed that other legal entities participate in theproject, in addition to the applicant legal entity, is their participation fully justified by the

scientificadded value they bring to the project?

FP7 / IDEASStarting Grants / Evaluation criteria

FP7 / IdeasStarting Grants / Peer review panel

Social Sciences

SH1 Individuals and organisations: Economics, management, demography, geography, urban and environmental studies.SH2 Institutions, behaviour, values and beliefs: Anthropology, sociology, political science, law, communication, social studies of science and technology.SH3 The human mind and its complexity: Cognition, linguistics, psychology and philosophy.SH4 Cultures and cultural diversity: Literature, visual and performing arts, music and cultural studies.SH5 The study of the past and of cultural artefacts: Memory, history and archaeology.

FP7 / IdeasStarting Grants / Peer review panel

Natural Sciences & EngineeringPE1 Mathematical foundations: Pure and applied mathematics, theoretical

computer science and mathematical physics.PE2 Fundamental constituents of matter: High energy, particle, nuclear, plasma, atomic, molecular, gas and optical physics.PE3 Structures and reactions: Condensed matter (structure, electronic properties, fluids,…), statistical physics, nanosciences, reactions.PE4 Material sciences and methods: Material sciences, molecular architecture, analytical chemistry, synthesis (both inorganic and organic) and theory, physical and environmental chemistry, method development.PE5 Information and communication: Informatics and information systems,

communication technology, computer science, intelligent systems.PE6 Engineering sciences: Electronics, product design, process design & control, construction methods, fluid and solid mechanics, energy systems, bio-

engineering.PE7 Universe sciences: Astro-physics/chemistry/biology/geology; solar system; stellar, galactic and extragalactic astronomy; cosmology; space sciences, instrumentation.PE8 Earth system science: Physical geography, geology, geophysics,

oceanography, climatology, ecology, global change, biogeochemical cycles, natural resources.

FP7 / IDEASStarting Grants / Peer review panel

Life SciencesLS1 Molecular, cellular and developmental biology: Biochemistry, molecular biology, metabolism, cell biology, signal transduction, embryology, structural biology.LS2 Genetics, genomics, bioinformatics and systems biology: Molecular genetics, cell genetics, genomics, transcriptomics, metabolomics, computational biology, biostatistics, biological modelling.LS3 Organismic physiology, including infection and immunity: Organogenesis, organ

physiology, endocrinology, ageing, toxicology, parasitology, microbiology, virology, immunology.LS4 Neurosciences: Neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, systems neuroscience, neuroimaging.LS5 Evolutionary, population and environmental biology: Evolution, adaptation, population biology, biodiversity, ecotoxicology, marine biology, radiation biology,

environmental risks, environmental medicine.LS6 Applied medical and health sciences: Clinical medicine, public health, psychiatry, surgery, epidemiology, biomedical engineering, veterinary medicine, pharmacology, medical ethics.LS7 Applied biology and bioengineering, including agricultural sciences and

biotechnology: Genetic engineering, GMOs, synthetic biology, plant biology,

fisheries, forestry,environmental biotechnology, industrial biotechnology,biomaterials, biohazards

OBJECTIVE-> TO MAKE EUROPE MORE ATTRATIVE FOR THE BEST RESEARCHERS

http://cordis.europa.eu/fp7/people

Scope

• Human resource development in R&D in Europe

• Numerous, well-trained, motivated researchers

• Attract students to research careers

• Attract researchers to Europe and retain skills and sustainable career development

• Appropriate gender balance

FP7 / PeopleHuman

potential

FP7 / PeopleActivities/ 1st calls for

proposals

• Initial training of researchers - Marie Curie Networks

FP7-PEOPLE-2007-1-1-ITN 7 May-25 Sept 2007

• Life-long training and career development– Individual Fellowships (IEF)

FP7-PEOPLE-2007-2-1-IEF 14 August 2007

- Co-financing of regional/national/international programmesFP7-PEOPLE-2007-2-3-COFUND 17 Oct 2007

• Industry-academia pathways and partnerships- Industry-Academia Scheme

FP7-PEOPLE-2007-3-1-IAPP 31 May 2007

FP7 / PeopleActivities/1st call for proposals

• International dimension - Outgoing International FellowshipsFP7-PEOPLE-2007-4-1-IOF 14 August 2007

- Incoming International FellowshipsFP7-PEOPLE-2007-4-2-IIF 14 August 2007

- Reintegration grantsFP7-PEOPLE-2007-4-3-IRG

Continuous submission with "cut-off dates" for proposals received until 25 April and 17 Oct 2007

• Specific actions- Excellence awards

FP7-PEOPLE-2007-5-2-AWARDS 29 March 2007- Researchers' night

FP7-PEOPLE-2007-5-1-1-NIGHT 3 April 2007

FP7 / CapacitiesResearch Capacity

OBJECTIVE-> TO UNDERPIN THE NEEDS TO PERFORM RESEARCH

http://cordis.europa.eu/fp7/capacities

• Research Infrastructures INFRA-2007-2-2.27 Pan-European R I for

Nano-structures 1715 M€

• Research benefit of SMEs FP7-SME-2007-1 1336 M€

• Regions of Knowledge 126 M€

• Research Potential 340 M€

• Science in Society 330 M€

• International Cooperation 180 M€

• Coherent Development of Policies 70 M€

Conditions for participation

• Minimum condition, general rule, at least 3 independent participants from 3 different MS or Ac

• Additional conditions can be established by the SP or WP (number or type of participant, place of establishment)

• Specific conditions may also apply for:

– Frontier research actions, at least 1 legal entity established in a MS or Ac

– Collaborative projects addressing the participation of International Cooperation Partner Countries (ICPC) minimum is 4 participants, 2 of which from MS or Ac and another 2 from ICPC countries unless otherwise foreseen in the WP

UpperUpper funding limits (1)funding limits (1)

• Reimbursed will be according to the type of action and/or activity

• Research and technological development activities: up to 50% of eligible costs, or up to 75% for:• Non profit public bodies • secondary and higher education establishments• research organisations• SMEs• Security related research, for highly reliable capabilities with

impact on security of European citizens and targeted to a limited number of public users

• Demonstration activities: up to 50%

• Other activities including management: up to 100%

Upper funding limits (2)Upper funding limits (2)

Actions that will be reimbursed up to 100%:

• Frontier research

• Coordination and support actions

• Training and career development of researchers

Maximum reimbursement

rates of eligible costs

Research and technological

development (*)

Demonstration

activities

Management

of the consortium

activities

Other

activities (**)

Network of excellence

50%

75% (***)

100%

100%

Collaborative

project

50%

75% (***)

50%

100%

100%

Coordination and support

action

100% (****)

100% (****)

(*) Research and technological development includes operational activities directly related to the protection of foreground and coordination of research activities. (**) Other activities means any "specific activity" covered by Annex I. (***) For beneficiaries that are non profit public bodies, secondary and higher education establishments, research organisations and SMEs (****) The reimbursement of indirect eligible costs, in the case of coordination and support actions, may reach a maximum 7% of the direct eligible costs, excluding the direct eligible costs for subcontracting and the costs of reimbursement of resources made available by third parties which are not used on the premises of the beneficiary.

Reimbursement of eligible costsReimbursement of eligible costs

• Most funding schemes, particularly at beginning of FP7 will use reimbursement of eligible costs

Eligible

• actual (average personnel costs may be used if do not differ significantly from actual)

• incurred during duration of project

• in accordance with the beneficiary usual accounting and management principles

• recorded in the accounts of beneficiary

• used for the sole purpose of achieving the objectives of the project

Non-eligible (identifiable indirect taxes including VAT…)

Indirect CostIndirect Cost

• Participants may charge eligible direct and indirect costs

• Reimbursement of indirect costs:– For all:

• either actual overhead, or simplified method, or• flat rate of 20% of direct costs

– For Non profit Public Bodies, Secondary and Higher Education establishments, Research Organisations, and SMEs unable to identify real indirect costs, may apply for a flat rate of 60% for funding schemes with Research, Technological Development & Demonstration

– For Coordination and Support Actions limit of 7% of direct costs

Certification on the methodologyCertification on the methodology

• It aims at certifying the methodology of calculating (average) personnel costs and overhead rates

• Waives the obligation of certificates for interim payments

• Simplified certificate for final payments

• Valid throughout FP7, on a voluntary basis, must be accepted by the EC

• Particularly aimed at legal entities with multiple participation

Certification on Certification on financial statements financial statements

Under FP7 we do not talk anymore about audit certificates but about certificate on financial statements (CFS)

Certificate on financial statements:

• Mandatory when requested funding reaches 375,000 Euro per beneficiary (except for project of 2 years or less: CFS submitted at the end)

• If above the threshold, mandatory for every beneficiary, except if a certification on the methodology is provided

Risk avoidance mechanism (1)Risk avoidance mechanism (1)

Participant Guarantee Fund (“the Fund”):

• All beneficiaires contribute to the Fund to insure against losses of a defaulting participant

• The contribution shall not exceed 5% of the EC financial contribution due to each participant

• Financial interests generated by the Fund will serve to cover financial risk

• In principle this amount will be reimbursed at the end of the action

TerminologyTerminology

Sources: Financial Regulation/Implementing Rules, FP7 and Rules for Participation

• “Contract” becomes “Grant Agreement”• “Contractor” becomes “Beneficiary”• “Instruments” become “Funding Schemes”• “Audit certificate” becomes “Certificate on

Financial Statement”• The results of the project (knowledge in FP6)

becomes “Foreground”• Pre-existing know-how becomes “Background”

Consortium agreementConsortium agreement

• Unless exempted by the call for proposals, participants will have to draw up a “consortium agreement”, to govern the following:

• (a) The internal organisation of the consortium

• (b) The distribution of the Community financial contribution

• (c) Additional rules on dissemination and use including intellectual property rights arrangements, as appropriate

• (d) The settlement of internal disputes.

Who evaluates proposalsHow to become evaluator for FP7

Cooperation

The Commission invites individuals to apply as prospective independent experts in order to be included in its database of experts for the Seventh Framework Programme

http://cordis.europa.eu/emmfp7

Who evaluates proposalsHow to become evaluator for FP7

IdeasThe Commission has invited the Member States to submit

candidates as independent experts in order to be included in its specific database as panel Chairs and panel members and a pool of referees.

Panel Chairs are expected to be internationally recognised, senior scientists in their fields.

Panel members are expected to be senior scientists in their fields, actively pursuing research at the front line.

Further information

Information research programmes projects:

http://cordis.europa.eu/fp7EU research: http://europa.eu.int/comm/research

RTD info magazine: http://europa.eu.int/comm/research/rtdinfo

Single Helpdesk: Research Enquiries Service

http://ec.europa.eu/research/enquiries

FP722May07_slides_AR_AS_Athens.ppt

Technology

cp new materials

cp nanostructured materials

cp basic research

cp renewable materials

large cp organic materials

cp nanostructured catalysts

cp nanostructured coatings

large cp coordination